Page 35 - Exact Sciences News Today

The best healthcare ETFs patch investors into an area of the market that offers both defensive properties and long-term growth.

Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures. In total, Viome has raised $175 million.

Aging is malleable, at least in animal models. But to prove the efficacy of interventions aimed at extending healthspan and to test life-extending approaches in humans, longevity researchers first need to agree on the best measuring tools. With the power of ’omics, AI and large biobanks, improved biomarkers may be forthcoming. Companies and academic researchers are rallying forces, but how far have they gotten? Aging is malleable, at least in animal models. But to prove the efficacy of int...

By summer 2021, Gilbert Milam Jr. was living a good life. A nationally renowned rapper who performs under the name Berner, Milam was also enjoying the global expansion of Cookies,

Resources Investment Advisors LLC. trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 96,686 shares of the medical research company’s stock after selling 3,507 shares during the period. Resources Investment Advisors […]

Investment analysts at StockNews.com assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the medical research company’s stock. Several other equities analysts have also issued reports on EXAS. The Goldman Sachs Group boosted their […]

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Connor Clark […]

Connor Clark & Lunn Investment Management Ltd. acquired a new position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Other institutional investors and […]

"Im so sorry, Mom, and my family and friends, Im sorry," Thomas Monson said in court Tuesday.